Afficher la notice abrégée

dc.contributor.authorPrasath, Ragul
dc.contributor.authorSinduja, Palati
dc.contributor.authorPriyadharshini
dc.date.accessioned2023-02-14T12:34:43Z
dc.date.available2023-02-14T12:34:43Z
dc.date.issued2023-01-19
dc.identifier.citationS.Ragul Prasath, Dr. Palati Sinduja, Dr. Priyadharshini (2022). Knowledge And Awareness on Various Treatment Modalities of Diabetes Mellitus -A Observational Survey Journal for Educators, Teachers and Trainers,Vol. 13(6). 190-198. DOI: [10.47750/jett.2022.13.06.017]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/79933
dc.description.abstractIntroduction: Diabetes mellitus (DM) is a group of metabolic disorders characterized by a high blood sugar level over a prolonged period of time. Patients suffer from various problems as a result of inadequate glycemic control. There are several treatment modalities available for treating control glycemia. However, many diabetic patients may not be aware of these options. This study was conducted to assess the knowledge and awareness on various treatment modalities of diabetes mellitus. Materials And Methods: A set of self designed questionnaires of 21 questions were framed and was circulated among diabetic patients through google forms link. The sample size that was chosen for the study was 100. The criteria used for choosing sample’s were chronic diabetic patients, middle and old age people. The questions were prepared and then analysed thoroughly before sharing the google forms link online. The result output variables were collected and represented in pie charts. Descriptive statistics and Chi square test were used to analyse the data obtained. Results: In the present study, Out of total participants 60.6% were Male and 39.4% were Female. 27.5% of the population were suffering from diabetes mellitus from past 1-5years-, 52.3% of the population were having diabetes mellitus from past 5-10 years and 20.2% of the population were having diabetes mellitus for > 10 years. 56.9% of diabetic patients were using metformin as the preliminary drug for the treatment of diabetes mellitus and 43.1% of patients were not using it. Majority of diabetic patients were prescribed glipizide as the drug of choice in the treatment of diabetes mellitus. 33% of diabetic patients were using glipizide, 25.7% of diabetic patients were using glimepiride & glibenclamide and 15.7% patients were not using any of them. Conclusion: Patients with diabetes haad fair knowledge and awareness about the different treatment modalities. Metformin, Glipizide (sulphonylureas) was preferred drugs for diabetes mellitus.es_ES
dc.description.sponsorshipSaveetha Institute of Medical and Technical Scienceses_ES
dc.language.isoenges_ES
dc.publisherUniversidad de Granadaes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDiabetes Mellituses_ES
dc.subjectTreatment of choicees_ES
dc.subjectEtiologyes_ES
dc.subjectAntidiabetic drugses_ES
dc.subjectInnovative techniquees_ES
dc.titleKnowledge And Awareness on Various Treatment Modalities of Diabetes Mellitus -A Observational Surveyes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.47750/jett.2022.13.06.017
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional